A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...

Researchers found the patches worked just as well as current injections at stopping the disease from progressing, while ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it spreads to bones or other areas.

We are right now on the cusp of the start of the seasonal water level rise on the Great Lakes. Let’s look at the status of the Great Lakes water levels. The snowmelt over the past few weeks has ...

High comorbidity as a predictor of poorer survival and ARPI efficacy in metastatic prostate cancer. Real-world characteristics of long-term survivors with metastatic castration-resistant prostate ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study released Tuesday found microplastics deep inside samples from 9 out of 10 patients with prostate cancer, with more ...

A new study released Tuesday found microplastics deep inside samples from 9 out of 10 patients with prostate cancer, with more microplastic levels inside tumors than in regular healthy tissue nearby.

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...